{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:14:45Z","timestamp":1788837285014,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004493","name":"International Atomic Energy Agency","doi-asserted-by":"publisher","award":["E13033"],"award-info":[{"award-number":["E13033"]}],"id":[{"id":"10.13039\/501100004493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00259-025-07218-x","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:13:17Z","timestamp":1743743597000},"page":"3757-3772","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["[177Lu]Lu-EDTMP \u2014a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2890-6886","authenticated-orcid":false,"given":"Shabana","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9268-0979","authenticated-orcid":false,"given":"Diana","family":"Paez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2597-8609","authenticated-orcid":false,"given":"Enrique","family":"Estrada Lobato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-6513","authenticated-orcid":false,"given":"Roberto C.","family":"Delgado Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghazal","family":"Jameel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Pellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Brink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Grigoryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Knoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0550-7893","authenticated-orcid":false,"given":"Francesco","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"7218_CR1","unstructured":"URL:http:\/www.insightec.com\/135-en-r10\/BoneMetastasis.aspx (Pain Palliation of Bone Metastasis). Last accessed August 23, 2024."},{"issue":"50","key":"7218_CR2","first-page":"1","volume":"13","author":"S Chiacchio","year":"2010","unstructured":"Chiacchio S, Borso E, Alsharif AA, Boni G, Mariani G. Radiopharmaceuticals for pain palliation therapy in patients with skeletal metastasis, and their possible integration with chemotherapy. AJ. 2010;13(50):1\u20135.","journal-title":"AJ"},{"key":"7218_CR3","unstructured":"Criteria for Palliation of Bone Metastases. TECDOC-1549. IAEA, Vienna, 2007. http:\/\/www.pub.iaea.org\/MTCD\/publications\/PDF\/te_1549_web.pdf. Last accessed August 23, 2024."},{"issue":"20","key":"7218_CR4","doi-asserted-by":"publisher","first-page":"6243","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"EC Robert","year":"2006","unstructured":"Robert EC. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res. 2006;12(20):6243\u20139.","journal-title":"Clin Cancer Res"},{"key":"7218_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1387\/ijdb.041817lv","volume":"48","author":"AM Luc","year":"2004","unstructured":"Luc AM, Vakaet L, Tom B. Pain control by ionizing radiation of bone metastasis. Int J Dev Biol. 2004;48:599\u2013606.","journal-title":"Int J Dev Biol"},{"key":"7218_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13139-017-0509-2","volume":"52","author":"JY Choi","year":"2018","unstructured":"Choi JY. Treatment of bone metastasis with bone-targeting radiopharmaceuticals. Nucl Med Mol Imaging. 2018;52:200\u20137. https:\/\/doi.org\/10.1007\/s13139-017-0509-2.","journal-title":"Nucl Med Mol Imaging"},{"key":"7218_CR7","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s00259-018-3947-x","volume":"45","author":"D Handkiewicz-Junak","year":"2018","unstructured":"Handkiewicz-Junak D, Poeppel TD, Bodei L, Aktolun C, Ezziddin S, Giammarile F, et al. EANM guidelines for radionuclide therapy of bone metastases with beta-emitting radionuclides. Eur J Nucl Med Mol Imaging. 2018;45:846\u201359. https:\/\/doi.org\/10.1007\/s00259-018-3947-x.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7218_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1007\/s00259-017-3913-z","volume":"45","author":"RC Delgado Bolton","year":"2018","unstructured":"Delgado Bolton RC, Giammarile F. Bone radionuclide therapy and increased survival with radium-223 is the way to go for nuclear medicine: the offer that oncologists cannot refuse. Eur J Nucl Med Mol Imaging. 2018;45:822\u20133. https:\/\/doi.org\/10.1007\/s00259-017-3913-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7218_CR9","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/RLU.0000000000004919","volume":"49","author":"LS Almeida","year":"2024","unstructured":"Almeida LS, Etchebehere ECSC, Garc\u00eda Meg\u00edas I, Calapaqu\u00ed Ter\u00e1n AK, Hadaschik B, Colletti PM, et al. PSMA radioligand therapy in prostate cancer: where are we and where are we heading? Clin Nucl Med. 2024;49:45\u201355. https:\/\/doi.org\/10.1097\/RLU.0000000000004919.","journal-title":"Clin Nucl Med"},{"key":"7218_CR10","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1007\/s00259-019-04485-3","volume":"46","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Fendler WP, Eiber M, Baum R, Bozkurt MF, Czernin J, et al. EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2019;46:2536\u201344. https:\/\/doi.org\/10.1007\/s00259-019-04485-3.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7218_CR11","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1007\/s00259-023-06255-8","volume":"50","author":"C Kratochwil","year":"2023","unstructured":"Kratochwil C, Fendler WP, Eiber M, Hofman MS, Emmett L, Calais J, et al. Joint EANM\/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging. 2023;50:2830\u201345. https:\/\/doi.org\/10.1007\/s00259-023-06255-8.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"14","key":"7218_CR12","first-page":"4829","volume":"25","author":"U Elboga","year":"2021","unstructured":"Elboga U, Kilbas B, Sahin E, Cay\u0131rl\u0131 YB, Eryilmaz K, Begec T, Bakar HE, Mercanoglu G, Celen YZ. An automated synthesis of 177Lu-EDTMP as an efficient bone-seeking therapeutic radiopharmaceutical. Eur Rev Med Pharmacol Sci. 2021;25(14):4829\u201334.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"7218_CR13","first-page":"383","volume":"36","author":"E Askari","year":"2021","unstructured":"Askari E, Harsini S, Vahidfar N, Divband G, Sadeghi R. 177Lu-EDTMP for metastatic bone pain palliation: a systematic review and meta-analysis. Cancer Biother Radiopharm. 2021;36:383\u201390.","journal-title":"Cancer Biother Radiopharm"},{"key":"7218_CR14","unstructured":"American Cancer Society. Cancer facts and figures. 2007. URL: http:\/\/www.cancer.org\/downloads\/STT\/CAFF2007PWSecured.pdf. Last accessed August 23, 2024."},{"key":"7218_CR15","doi-asserted-by":"crossref","unstructured":"Joseph G. Rajendran. Therapeutic Raidioisotopes. In: Silberstein EB, eds. Nuclear Medicine Therapy, 3rd ed. Informa health care New York, NY, 2007.","DOI":"10.3109\/9781420016642-3"},{"key":"7218_CR16","unstructured":"URL: http:\/\/www.mydr.com.au\/printerfriendly.asp?article=4190. Last accessed August 23, 2024."},{"issue":"3","key":"7218_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s00256-007-0404-5","volume":"37","author":"L Thonos","year":"2008","unstructured":"Thonos L, Mylona S, Galani P, et al. Radiofrequency ablation of osseous metastases for the palliation of pain. Skeletal Radiol. 2008;37(3):189\u201394.","journal-title":"Skeletal Radiol"},{"key":"7218_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1021\/cr9804386","volume":"99","author":"WA Volkert","year":"1999","unstructured":"Volkert WA, Hoffman TJ. Therapeutic radiopharmaceuticals. Chem Rev. 1999;99:22\u201369.","journal-title":"Chem Rev"},{"key":"7218_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0001-2998(05)80152-7","volume":"22","author":"F Hosain","year":"1992","unstructured":"Hosain F, Spencer RP. Radiopharmaceuticalsfor palliation of metastatic osseous lesions: Biologic and physical background. Semin Nucl Med. 1992;22:11.","journal-title":"Semin Nucl Med"},{"key":"7218_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1148\/radiology.134.1.6153129","volume":"134","author":"A Cheung","year":"1980","unstructured":"Cheung A, Driedger AA. Evaluation of radioactive phosphorus in the palliation of metastatic bone lesions from carcinoma of breast and prostate. Radiology. 1980;134:209.","journal-title":"Radiology"},{"key":"7218_CR21","unstructured":"O\u2019Mara RE. New P-32 compounds in therapy of bone lesions. In: Therapy in nuclear medicine (Spencer RP, ed.). Grune and Stratton, New York, 1978, p. 257."},{"key":"7218_CR22","first-page":"219","volume":"14","author":"RG Robinson","year":"1987","unstructured":"Robinson RG, Spicer JA, Preston DF, et al. Treatment of metastatic bone pain with stroncium-89. Nucl Med Biol. 1987;14:219.","journal-title":"Nucl Med Biol"},{"key":"7218_CR23","first-page":"2011","volume":"31","author":"J Shine","year":"1990","unstructured":"Shine J, Amir D, Soskolne WA, et al. Correlation between uptake of technetium, calcium, phosphate and mineralization in rat tibial bone repair. J Nucl Med. 1990;31:2011.","journal-title":"J Nucl Med"},{"key":"7218_CR24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0969-8043(03)00158-1","volume":"59","author":"MRA Pillai","year":"2003","unstructured":"Pillai MRA, Chakraborty S, Das T, et al. Production logistics of 177Lu for radionuclide therapy. Appl Radiat Isot. 2003;59:109.","journal-title":"Appl Radiat Isot"},{"key":"7218_CR25","first-page":"495","volume":"28","author":"WF Goeckeler","year":"1987","unstructured":"Goeckeler WF, Edwards B, Volkert WA, et al. Skeletal localization of samarium-153 chelates: Potential therapeutic bone agents. J Nucl Med. 1987;28:495.","journal-title":"J Nucl Med"},{"issue":"3\u20134","key":"7218_CR26","first-page":"157","volume":"88","author":"SGA Rutty","year":"2000","unstructured":"Rutty SGA, Arguelles MG, Bottazzini DL, Furnari JC, Gomez Parada I, Rojo AM, Vera RH. Lutetium-177-EDTMP for bone pain pallation. Preparation, biodistribution and pre-clinical studies. Publicado Radiochim. 2000;88(3\u20134):157\u201361.","journal-title":"Publicado Radiochim"},{"key":"7218_CR27","first-page":"223","volume":"14","author":"AR Ketring","year":"1987","unstructured":"Ketring AR. 153Sm-EDTMP and 186Re-HEDP as bone therapeutic radiopharmaceuticals. Nucl Med Biol. 1987;14:223.","journal-title":"Nucl Med Biol"},{"key":"7218_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1097\/00006231-200201000-00011","volume":"23","author":"S Chakraborty","year":"2002","unstructured":"Chakraborty S, Das T, Unni PR, et al. 177Lu-labeled polyaminophosphonates as potential agents for bone pain palliation. Nucl Med Commun. 2002;23:67\u201375.","journal-title":"Nucl Med Commun"},{"issue":"2","key":"7218_CR29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nucmedbio.2009.09.004","volume":"37","author":"D M\u00e1th\u00e9","year":"2010","unstructured":"M\u00e1th\u00e9 D, Balogh L, Poly\u00e1k A, Kir\u00e1ly R, M\u00e1ri\u00e1n T, Pawlak D, et al. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent. Nuclear Med Biol. 2010;37(2):215\u201326.","journal-title":"Nuclear Med Biol"},{"issue":"1","key":"7218_CR30","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2174\/1874471008666150313105000","volume":"9","author":"C Bal","year":"2016","unstructured":"Bal C, Arora G, Kumar P, Damle N, Das T, Chakraborty S, Banerjee S, Venkatesh M, Zaknun JJ, Pillai MR. Pharmacokinetic, dosimetry and toxicity study of 1\u2077\u2077Lu-EDTMP in patients: phase 0\/I study. Curr Radiopharm. 2016;9(1):71\u201384.","journal-title":"Curr Radiopharm"},{"key":"7218_CR31","first-page":"1814","volume":"30","author":"A Singh","year":"1989","unstructured":"Singh A, Richard A, Farhangi M, et al. Human pharmacokientics of samarium-153-EDTMP in metastatic cancer. J Nucl Med. 1989;30:1814\u20138.","journal-title":"J Nucl Med"},{"key":"7218_CR32","first-page":"230","volume":"42","author":"W Brenner","year":"2001","unstructured":"Brenner W, Kampen WU, Kampen AM, Henze E. Skeletal uptake and soft-tissue retention of 186Re-HEDP and 153Sm-EDTMP in patients with metastatic bone disease. J Nucl Med. 2001;42:230\u20136.","journal-title":"J Nucl Med"},{"key":"7218_CR33","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1002\/1097-0142(20000615)88:12+<2934::AID-CNCR9>3.0.CO;2-S","volume":"88","author":"AN Serafini","year":"2000","unstructured":"Serafini AN. Samarium Sm-153 lexidronam for the palliation of bone pain associated with metastases. Cancer. 2000;88:2934\u20139.","journal-title":"Cancer"},{"key":"7218_CR34","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1007\/s002590050153","volume":"24","author":"W Brenner","year":"1997","unstructured":"Brenner W, Bohuslavizki KH, Sieweke N, Tinnemeyer S, Clausen M, Henze E. Quantification of diphosphonate uptake based on conventional bone scanning. Eur J Nucl Med. 1997;24:1284\u201390.","journal-title":"Eur J Nucl Med"},{"key":"7218_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/RLU.0b013e318279bf4d","volume":"38","author":"J Yuan","year":"2013","unstructured":"Yuan J, Liu C, Liu X, et al. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: A phase II study. Clin Nucl Med. 2013;38:88.","journal-title":"Clin Nucl Med"},{"key":"7218_CR36","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00259-014-2862-z","volume":"42","author":"KK Agarwal","year":"2015","unstructured":"Agarwal KK, Singla S, Arora G, et al. 177 Lu-EDTMP for palliation of pain from bone metastases in patients with prostate and breast cancer: A phase II study. Eur J Nucl Med Mol Imaging. 2015;42:79.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7218_CR37","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/1450-1147.157124","volume":"14","author":"M Alavi","year":"2015","unstructured":"Alavi M, Omidvari S, Mehdizadeh A, et al. Metastatic bone pain palliation using 177Lu-ethylenediaminetetramethylene phosphonic acid. World J Nucl Med. 2015;14:109.","journal-title":"World J Nucl Med"},{"key":"7218_CR38","doi-asserted-by":"publisher","first-page":"46","DOI":"10.3389\/fmed.2017.00046","volume":"4","author":"S Sharma","year":"2017","unstructured":"Sharma S, Singh B, Koul A, et al. Comparative therapeutic efficacy of 153Sm-EDTMP and 177Lu-EDTMP for bone pain palliation in patients with skeletal metastases: Patients\u2019pain score analysis and personalized dosimetry. Front Med. 2017;4:46.","journal-title":"Front Med"},{"key":"7218_CR39","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.2967\/jnumed.115.155762","volume":"56","author":"P Thapa","year":"2015","unstructured":"Thapa P, Nikam D, Das T, et al. Clinical efficacy and safety comparison of 177Lu-EDTMP with 153Sm-EDTMP on an equiactivity basis in patients with painful skeletal metastases. J Nucl Med. 2015;56:1513.","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"7218_CR40","first-page":"1441","volume":"57","author":"B Singh","year":"2016","unstructured":"Singh B, Prashar S, Koul A, et al. Comparative therapeutic efficacy of 177Lu-EDTMP and 153Sm-EDTMP in bone pain palliation in cancer patients with multiple skeletal metastases. J Nucl Med. 2016;57(Suppl 2):1441.","journal-title":"J Nucl Med"},{"key":"7218_CR41","first-page":"270","volume":"19","author":"I Fogelman","year":"1978","unstructured":"Fogelman I, Bessent RG, Turner JG, Citrin DL, Boyle IT, Greig WR. The use of whole body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease. J Nucl Med. 1978;19:270\u20135.","journal-title":"J Nucl Med"},{"key":"7218_CR42","first-page":"330","volume":"19","author":"RA Holmes","year":"1987","unstructured":"Holmes RA. Quantification of skeletal Tc-99m labeled phosphates to detect metabokic bone disease. J Nucl Med. 1987;19:330\u20131.","journal-title":"J Nucl Med"},{"key":"7218_CR43","first-page":"1031","volume":"34","author":"JF Eary","year":"1993","unstructured":"Eary JF, Collins C, Stabin M, et al. Samarium-153-EDTMP biodistribution and dosimetry estimation. J Nucl Med. 1993;34:1031\u20136.","journal-title":"J Nucl Med"},{"key":"7218_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/00365518409161390","volume":"44","author":"L Hyldstrup","year":"1984","unstructured":"Hyldstrup L, Mogensen N, Jensen GF, McNair P, Transbol I. Urinary Tc-99m-diphosphonate excretion as a simple method to quantify bone metabolism. Scand J Clin Lab Invest. 1984;44:105\u20139.","journal-title":"Scand J Clin Lab Invest"},{"key":"7218_CR45","first-page":"280","volume":"34","author":"M Alavi","year":"2019","unstructured":"Alavi M, Khajeh-Rahimi F, Yousefnia H, et al. 177Lu\/153Sm-Ethylenediamine tetramethylene phosphonic acid cocktail: a novel palliative treatment for patients with bone metastases. Cancer Biother Radiopharm. 2019;34:280.","journal-title":"Cancer Biother Radiopharm"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07218-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07218-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T08:42:41Z","timestamp":1757148161000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07218-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["7218"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07218-x","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"20 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}